Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-13, Stock:JNJ, The news for the past five days is as follows:
2019-02-06: NEWS1: At least four pharma CEOs to testify at Senate drug pricing hearing.NEWS2: Sightbox CEO on life after acquisition and growth under J&J.NEWS3: Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying.NEWS4: Health Care Sector Update for 02/06/2019: NVLN, AGLE, VNDA, JNJ, PFE, MRK, ABT, AMGN.NEWS5: Health Care Sector Update for 02/06/2019: NVLN, AGLE, VNDA, JNJ, PFE, MRK, ABT, AMGN.NEWS6: Pfizer CEO Bourla plans to testify at Senate drug pricing hearing.NEWS7: Winners & Losers from Trump's State of the Union Address.NEWS8: Winners & Losers from Trump's State of the Union Address.NEWS9: Winners & Losers from Trump's State of the Union Address.
2019-02-07: NEWS1: J&J becomes first drugmaker to add prices to television ads.NEWS2: Johnson & Johnson will list drug prices in TV commercials.NEWS3: Johnson & Johnson will list drug prices in TV commercials.NEWS4: DBC, SHE: Big ETF Outflows.NEWS5: DBC, SHE: Big ETF Outflows.NEWS6: Health Care Sector Update for 02/07/2019: LCI, OSUR, CAH, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 02/07/2019: LCI, OSUR, CAH, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Swiss Idorsia says 'stay tuned' for deals as it manages pipeline.NEWS9: Idorsia will take three to four years to reach profitability, CEO says.
2019-02-08: NEWS1: Here&apos;s Why Arrowhead Pharmaceuticals Gained as Much as 15.8% Today.NEWS2: Johnson & Johnson Rolls Out a New Trump Appeasement Policy.NEWS3: Health Care Sector Update for 02/08/2019: APOP, SGEN, MBOT, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Health Care Sector Update for 02/08/2019: APOP, SGEN, MBOT, JNJ, PFE, ABT, MRK, AMGN.NEWS5: The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs.NEWS6: Apple teams up with Johnson & Johnson to help prevent strokes.NEWS7: See what the IHS Markit Score report has to say about Johnson & Johnson..
2019-02-11: NEWS1: SEC&apos;s Clayton says agency right not to rule on Johnson & Johnson shareholder proposal concerning mandatory arbitration.NEWS2: SEC's Clayton says agency right not to rule on Johnson & Johnson shareholder proposal concerning mandatory arbitration.NEWS3: FDA Panel Reviews Johnson & Johnson's Treatment-Resistant Depression Candidate: What To Expect.NEWS4: What Are Analysts Saying About Johnson & Johnson’s (NYSE:JNJ) Growth?.
2019-02-12: NEWS1: J&J's nasal spray for depression wins FDA panel backing.NEWS2: U.S. FDA panel recommends approval of Johnson & Johnson's depression drug.NEWS3: Dow Analyst Moves: JNJ.NEWS4: Dow Analyst Moves: JNJ.NEWS5: [$$] SEC Allows Rejection of Mandatory Shareholder Arbitration.NEWS6: ARWR’s 2019 Goals Include Data From Several Studies, Initiation of Ph2 ARO-AAT.NEWS7: Health Care Sector Update for 02/12/2019: KMDA, GILD, MDGS, JNJ, PFE, MRK, ABT, AMGN.NEWS8: Health Care Sector Update for 02/12/2019: KMDA, GILD, MDGS, JNJ, PFE, MRK, ABT, AMGN.NEWS9: The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares.NEWS10: [$$] SEC Rejects Proposal for Mandatory Shareholder Arbitration.

Answer: Rise